A B S T R A C T Metabolic clearance rates of testosterone (MCRT) and androstenedione (MCRA) were determined twice during the same cycle in six normal women, using a constant infusion of testosterone-2H and androstenedione-"C. Nonlabeled steroids served as internal standards. Plasma concentrations of testosterone (iT) and androstenedione (iA) were measured, and the blood production of testosterone (PBT) and of androstenedione (PBA) were calculated. The interconversions of these two steroids were also estimated. Six ovariectomized women were studied in the same manner. For testosterone, the mean i in the normal women was not significantly different from that in the ovariectomized subjects, whereas the MCRT and PET were significantly lower in the ovariectomized subjects. For androstenedione, the mean MCRA values of the two groups of subjects were not different, whereas the iA and PBA in the normal women were about double those in the ovariectomized subjects. In comparing the follicular and luteal phases of the menstrual cycle in four of six subjects there was no difference in iT, MCRT, or PBT, whereas iA, MCRA, and PBA were increased in the luteal phase. In one ovariectomized woman infused with testosterone and androstenedione at physiologic levels, MCRT doubled but MCRA remained the same. After six wk on estrogen, the same subject did not show any change in MCRT after infusion of testosterone. It is suggested that MCRT depends on PBT and on plasma binding of testosterone which is partly estrogen dependent.
INTRODUCTION
Androgen metabolism in the human is so complex (1-3) that a comprehensive study involving the same sub-jects would be most meaningful. As almost every physiologic measurement studied in the human female seems to be influenced by the ovarian cycle (4) , an accurate timing of this cycle is obviously a prerequisite for a worthwhile evaluation and comparison of the data obtained. Two factors are of prime importance in deciding which parameters should be sudied: first, the availability and reliability of methods for measurement, and second, the clinical usefulness of the data obtained by these methods. In the field of androgens, attention is usually directed to the most potent androgen known, testosterone. Since androstenedione is readily interconvertible with testosterone (1, 5-7), the former should be included in investigations of androgen metabolism. Several methods have been described for the measurement of the production rate and interconversion of specific androgens. The advantages of the "blood" methods over the 'urinary" methods have been emphasized by Tait and Burstein (2) and Horton and Tait (5) . Those advantages hold true more so when the production rate of testosterone is measured in women, since most of the urinary testosterone glucuronide which is assumed to be the unique metabolite of testosterone in the "urinary" methods derives mainly from androstenedione by direct hepatic conversion to testosterone glucuronide without ever entering the circulation as free testosterone (8) . Therefore, using the concept of metabolic clearance rate (2, 9) and the adaptation of this concept to the measurement of the blood production rate of testosterone and androstenedione (5) , we have studied the dynamics of these two androgens during the menstrual cycle in normal women and also in ovariectomized subjects.
METHODS
Subjects. The subjects studied consisted of two groups (Table I) . Group I included normally menstruating, adult women who claimed to be on no medication during the study period. Basal body temperatures were obtained daily. Urinary pregnanediol was determined on days 10 and 22 of the cycle. By use of these indirect indices of ovulation, five of the six subjects had an ovulatory cycle. (Subject No. 5 had a flat temperature curve, and there was no increase in urinary pregnanediol.) An attempt was made to perform one infusion experiment during the follicular phase and another infusion during the luteal phase of the same cycle. It was successful in four of the subjects. The second infusion on subject No. 4 was performed on the day of thermal nadir (TN = 0). Thermal nadir was considered as the demarcation line between the follicular and the luteal phases of the cycle. Group II consisted of six ovariectomized women who were otherwise in good general health and on no medication for at least 6 wk before the study period.
Infusion experiments. Testosterone-1,2-3H (specific activity 42 c/mmole) and androstenedione-4-'4C (specific activity 50 mc/mmole) were obtained from New England Nuclear Corp., Boston, Mass., and found to be over 95%o pure by scanning of the chromatogram after chromatography on a Bush system (stationary phase, methanol: water 85: 15; mobile phase, Skelly C). A mixture of the two radioactive steroids was prepared in a 22 ml solution of 10%o ethanol in normal saline just before the infusion. Approximately 10-20 /Ac of testosterone-3H and 2-4 /Ac of androstenedione-"C were used. Sterilization of the infusion solution was achieved by passing it through a 0.5 A Millipore filter. There was no significant loss of either steroid on the filtration apparatus.
After the fasting subjects had been in the decubitus position from 8 to 9 a.m., 50 ml of venous blood was drawn into heparinized syringes from the left cubital vein with a No. 18 Rochester needle which was left in place for further use. This sample was used to determine the plasma levels of testosterone and androstenedione. A solution of isotonic NaCl was administered intravenously through the right cubital vein with a No. 18 Rochester needle. At 9:30 a.m. .a loading dose of the infusion mixture consisting of about -one-third of the total amount of radioactivity administered i(7 ml volume from a total of 22 ml) was slowly injected -through the rubber section of the IV tubing. At 10 a.m. the infusion was started through a Teflon tubing (10) with a Harvard constant infusion pump at a rate of 0.0764 ml/min. Samples collected for 5 min from the Teflon tubing pre-and postinfusion were used to calculate the delivery rate of the radioactive steroids. The infusion was continued for a period of 2 hr. These data are presented in Table II . In subject No. 8 the infusion was extended to 4 hr, using a larger volume of the two radioactive steroids, but at the same concentrations as in the other subjects. 50 ml of venous blood was drawn into heparinized syringes at 90, 105, and 120 min after the start of the infusion. These samples were used to study the metabolic clearance rate and conversion ratio of the two steroids. In subject No. 8, after the 120 min blood sample was drawn, a constant infusion of a 10%o ethanol solution in normal saline of testosterone and androstenedione was started with another Harvard pump at a rate of 0.0764 ml/min, corresponding to a delivery rate of 0.5 gg/min for testosterone and 3.0 /Ag/min for androstenedione.
This second infusion was continued for 2 hr while the radioactive steroid infusion was still running. 25 ml of venous blood was drawn in the same manner at 30, 60, 90, 105, and 120 min after the start of the second infusion. Those samples were used only to determine the metabolic clearance rate. The blood samples were centrifuged immediately after being drawn, and the plasma obtained was kept frozen until assayed.
Plasma steroids. Plasma testosterone and androstenedione were estimated by combining the double-isotope techniques using thiosemicarbazide-8S as described by Riondel et al. for testosterone (11) with the modification of Lobotsky, Wyss, Segre, and Lloyd (12) and as described by Horton for androstenedione (13) with the modification of Mizuno et al. (14) . 10-20 ml of plasma was assayed. The blank of the method (1 ng/sample for testosterone and androstenedione) was subtracted from the values obtained.
The metabolic clearance rates of testosterone (MCRT) and of androstenedione (MCRA) were measured by the technique of Horton and Tait (5) , and their abbreviations photometer. The standard steroids were read against pure ethanol and the unknowns against the paper blanks. The recovery of each steroid was estimated in this manner. The remaining 7 ml of ethanolic solution in the counting vials was evaporated, counting fluid was added, and after mixing, the samples were assayed for 'H and "C content with a Nuclear-Chicago liquid scintillation spectrometer model 720. Discriminator and gain settings were such that the efficiency for 'H was 15%o and for "C 42%. The efficiency for 'H in the "C channel was less than 0.19%, and the efficiency for "C in the 'H channel was 5%. For the errors involved in radioactivity measurements, see section on errors of the method. At no time were there any counts in the 'H and "C channels above background when the paper blanks were counted. No quenching effect could be detected for either of the two isotopes. Samples were counted for 10 X 20 min. The metabolic clearance rate was calculated from the rate of infusion of the isotope divided by the concentration of isotope in the specific steroid per volume of plasma. Evidence that the infused steroids reached equilibrium during the 2 hr period was provided by the fact that there was no trend in the three values, and the coefficient of variation for these three samples was less than 10%b for the testosterone-5H and for the androstenedione-"C, and less than 20%o for androstenedione-'H and testosterone-"4C except in subject Nos. 1 and 2 where the coefficient of variation of androstenedione-'H was over 20%o. Those latter values, for this reason, are not included in this study.
Evidence for radiochemical purity of the testosterone and androstenedione fractions obtained in this way was presented by Horton and Tait (5) . Additional evidence was obtained for testosterone-5H and androstenedione-"C. One subject, infused during the follicular phase of her cycle, was dropped from the study. Her plasma samples were processed as described above. The paper eluates were pooled for each of the two steroids (total plasma volume, 60 ml). 15 mg each of testosterone and androstenedione was added to the corresponding paper eluate. This was mixed and an aliquot taken for estimation of specific activity. The remaining volume was dried down and the residue redissolved in ether. After three successive crystallizations in ether: hexane, the variations observed in the specific activity of testosterone-'H and androstenedione-"4C were within the error of the method.
(The specific activity in counts per minute per milligram for the eluate, the 1st, 2nd, and 3rd crystallizations were 92, 95, 91, and 91 for testosterone-5H and 24, 22.4, 23.6, and 22.8 for androstenedione-4C.)
Calculations. The symbols and calculations for the several parameters of the testosterone-androstenedione system are those of Horton and Tait (5) . The superscripts indicate the steroid, the subscripts the compartment. The symbol Z refers to the isotope in testosterone and X to the isotope in androstenedione. The formulas used are as follows: higher (P <0.01) in the normal than in the ovariectomized subjects (see Table III ). PBT showed no significant change during the two phases of the menstrual cycle, whereas PBA increased significantly (P < 0.01) in the luteal phase (Fig. 3) .
Conversion ratios and [p] values. The conversion
ratio of androstenedione to testosterone in blood (CodAT) and vice versa (CBBTA) were the same in group I subjects as those obtained in group II subjects. Also, these conversion ratios showed no difference between the follicular and luteal phases. These values are summarized in With the above data, and assuming that the endogenously produced steroids are completely mixed with the radioisotopically labeled steroids infused and that they follow the same metabolic pathway, it is estimated that 33% of iT in the normal subjects is derived from iA. Also, 37% of PBT is derived from PBA. On the other hand, the contribution of iT and PBT to iA and PBA was insignificant (less than 1%).
In the ovariectomized subjects 20% of iT and of PBT is derived respectively from iA and PBA. : Premarin (1.25 mg/day X 6 wk).
Effect of the acute administration of testosterone and androstenedione at physiological level on MCRT and MCRA. To study the effect of PBT and PBA upon MCRT and MCRA, subject No. 8 was infused with testosterone and androstenedione after blood samples were drawn for determination of MCRT and MCRA. The details of this experiment are described in the Methods section. The results of this infusion are shown in Fig. 4 . The rate of testosterone and androstenedione infused corresponds to a PBT of 720 ,ug/day and to a PBA of 4320 ,Ag/day, which are within physiologic levels for the normal female subjects studied (group I). Yet, the MCRT almost doubled under these conditions, whereas MCRA remained essentially the same. This subject (No. 8) was then placed on oral estrogen therapy for 6 wk (Premarin,1 1.25 mg/day) and the same experiment as described above was repeated. The results are summarized in Table IV . The MCRT under basal conditions was slightly lower than before estrogen treatment (540 liters/ 24 hr compared with 626 liters/24 hr). The infusion of testosterone at a rate of 0.5 /Ag/min did not significantly influence MCRT after estrogen therapy. When comparing either before and after estrogen administration, or before and after androstenedione infusion, no change was noted whatsoever for MCRA. DISCUSSION Testosterone. In the subjects studied, no change was observed in iT when the two phases of the menstrual cycle were compared. In a previous study with a larger number of subjects (12) , the highest iT during the menstrual cycle were found at about the time of thermal nadir. Since the present study did not cover every day of the menstrual cycle due to obvious practical difficulties, short-lived acute changes in any of the parameters studied might not have been detected.
Study of MCRT and PBT in the follicular and luteal phase of the normal menstrual cycle has not been previously reported. In the four subjects investigated no significant difference was found between the two phases of the menstrual cycle.
The mean PBs in the ovariectomized subjects was about half that in the normal women, but since the MCRT was also significantly lower in the ovariectomized women, this resulted in a mean iT not significantly different among these two groups. This finding does not necessarily mean that half of PET is contributed by the ovaries, since the two groups of subjects were in different age groups, and this factor might have contributed to this difference. In this regard, Kent and Acone reported (16) a lower MCRT and PBs in older men. The measurement of MCRT and PB in the same women before and after ovariectomy would help clarify this matter.
Correction for body weight and body surface did not affect this difference in MCRT between the normal and ovariectomized subjects.
Androstenedione. iA, MCRA, and PBA increased significantly in the luteal phase. This increase in PBA could be due to the contribution of the corpus luteum and the ovarian stroma as suggested by in vitro studies (17) .
iA and PBA in ovariectomized subjects were less than half those in normal subjects. Assuming that this difference is not due to age difference between the two groups of subjects, the conclusion can be drawn that the ovaries contributed to at least 50% of PET and PB'.
Horton, Romanoff, and Walker (18) found in five female patients undergoing surgery for metastatic breast cancer that the ovarian secretion of testosterone was quite small, and that the ovaries contributed less than one-fourth of PBA. Since these subjects were not normal, and since there is little information about androgen metabolism in patients with breast cancer, extrapolation of these findings to normal female subjects would be hazardous.
Horton and Tait (5) iA. This difference could be due to the lower iT levels found in a number of the female subjects studied by those two groups of investigators. Nevertheless, there is agreement on the important role of androstenedione as a prehormone (20) . Most of the CBBAT occurs outside of the liver (5, 21) . It is possible that this conversion occurs in target tissues where testosterone has a physiologic role. This role in the normal woman is not yet known. The uterus and the ovaries do not seem important in CBBAT, since these values were not different in normal and ovariectomized-hysterectomized subjects.
Effect of PBT on MCRT. Southern et al. (22) MCRT and PBs in normal and hirsute females. They interpreted this correlation as being consistent with a depression of a testosterone-binding protein by increased testosterone production.
We have been able to demonstrate an acute change in MCRT after infusion of a physiological dose of testosterone in an ovariectomized subject. In view of the results reported by others (23) , and since we only have one such experiment, a valid explanation for this finding must await more extensive studies. Nevertheless, acute and chronic changes produced by testosterone could either be due to an increase in hepatic blood flow or to induction of enzymes involved in the metabolism of testosterone. Another explanation, however, could come from the studies of Pearlman and Crepy (24) who showed a significant binding of testosterone by human plasma, and that this binding capacity of plasma was dependent upon estrogen (25) . Testosterone bound to plasma albumin can be considered as physiologically free testosterone since this binding is of low affinity (26) . On the other hand, testosterone is bound to a specific 8-globulin of limited capacity and high affinity, and its capacity is increased by estrogen treatment (26) . This latter protein could play an important role in the metabolism of testosterone, preventing rapid degradation by the liver and allowing certain target tissues possessing proteins with a high affinity for testosterone to selectively extract it from the blood. Studies involving concomitant evaluation of plasma binding capacity for testosterone together with the estimation of MCRT would shed some light on the physiological importance of this testosterone-binding protein.
APPENDIX
Errors of the method. The errors in the determination of RZT and RxA were always less than 5%. ZT and XA were obtained after correction for recovery was made with the optical density at 240 mpu (OD240). Since the paper blank for testosterone (OD240) varied from 0.008 to 0.020, with a range of 0.012, and the lowest reading of unknown samples was 0.270 (lowest recovery for testosterone, 45%), the maximum error in UV reading for testosterone was: 0.008/0.270 X 100 = 3%.
The paper blank for androstenedione varied from 0.012 to 0.022, with a range of 0.010. Since the lowest OD240 read for unknown samples was 0.325 (lowest recovery for androstenedione, 52%) the maximum UV reading error for androsteniedione would be: 0.010/0.325 X 100 = 3%. Therefore, by use of the formula ET = PE21 + E', + E2,, where ET = compounded error and El, E2, E3 represents respectively errors in delivery rate of radioactive steroids (RzT and RxA), in counting and in UV reading, then, the compounded error ET = <25 + 4 + 9 = '_i3 = 6.2%. This compounded error applied both for ZT and XA, for they both had the same maximum error in calculating delivery rate (5%), the same counting error (2%), and the same UV reading error (3%). Since only 70% of the recovered radioactive steroids was used for counting (7 out of 10 ml of ethanolic solution), the per cent of recovery was multiplied by the factor 0.7 to obtain the true recovery of the labeled steroids in the counting vials.
For ZT, XA, and XT, eoungh counts were accumulated to have a counting error of 2% or less. For ZA, however, the counting error was much greater. Using Horton and Tait's approach (27) in dealing with low 3H counts in the presence of high 14C counts, the counting error of ZA was obtained by applying the formula: % error = (100/H)I 2b + mc, where H = 3H count rates in the 3H channel; b = background count rates in the 3H channel; m = ratio of 14C count rates in the 'H channel over 14C count rates in the 14C channel; C = 14C count rates in the 14C channel; T = total counting time. With the gain settings used, b = 28, m = 0.12. A total of 200 min of counting time T were accumulated. The lowest count rate recorded for H was 9 cpm with a C value of 140 cpm; therefore, the maximum counting errors in the determination of ZA would be: % error = (100/9) /56+0.12 X 140 100/9 X 0.72 = 8%.
For the determination of XT and ZA, the compounded errors due to El, E2, and E3 were, respectively: for XT, MCRT and MCRA 48%
CBBAT ±9%, CBBTA ± 12%, [PIBBAT ±15%
[P]BBTA 1 7 %.
The errors involved in the determination of PBT and PBA are derived from the errors in calculating MCRT and MCRA on the one hand, and iT and iA on the other. The errors involved in the determination of iT and iA in the range studied are less than 10%. Therefore, the compounded errors for calculating PBT and PBA should be less than 15%o.
Statistical analysis. Student's t test (28) was used to compare data obtained from the normal female subjects (group I) with those obtained from the ovariectomized women (group II). When comparing the data obtained in the follicular phase with those obtained in the luteal phase in the same subjects, paired data analysis (28) was used.
